Search Results

240 results for CPLA

Coke — Not Pepsi — Tastes Better to Investors

Coca-Cola and Pepsi recently reported earnings, giving investors a fresh chance to measure up the two soft-drink giants. How do these companies stand up?

Strong Q3 Earnings Will Support Richly Valued Coca-Cola Stock

KO stock has sprinted to decade-high valuation levels, but strong Q3 numbers on Friday will support this stretched valuation.

3 Companies The Coca-Cola Co (KO) Should Buy in 2017

Soft drink giant Coca-Cola should continue to make acquisitions like FIZZ, MNST and PRMW to continue its diversification push.

Should I Buy Coca-Cola? 3 Pros, 3 Cons

Coca-Cola has been underperforming for a few months and took a hit Tuesday on less-than-spectacular earnings. Is it time to get out — or priced…

Coca-Cola Stock – Is KO Finally Cheap Enough to Buy?

As the U.S. appetite for soda drops, you might think Coca-Cola stock is a bad bet. But diverse brands and a solid dividend make KO…

Should You Buy Coca-Cola Stock (KO)? 3 Pros, 3 Cons

Coca-Cola stock has lagged the market for the past year, but are there any signs of recovery on the horizon?

Twilio Stock Is a Long-Term Winner, But Valuation Concerns Are Warranted

Long term upside in TWLO stock is compelling, but valuation friction may limit near term upside in shares.

Coke-Monster Is Bad News for Pepsi

Any partnership between the cola giant and the energy-drink leader will put Pepsi even further behind.

Coca-Cola: A Core Retirement Holding for Investors

Coca-Cola manufactures, distributes, and markets nonalcoholic beverages worldwide. This dividend king has paid uninterrupted dividends since 1894

The Post-Earnings Drop of Coca-Cola Stock Is a Buying Opportunity

Coca-Cola stock dropped big after Q4 earnings, but its long-term outlook indicates this drop has made KO stock more attractive.

Should I Buy Coca-Cola (KO)? 3 Pros, 3 Cons

Do the bulls or the bears have it right when it comes to Coca-Cola shares? We take a look at the pros and cons of…

Put Coca-Cola Back in Your Portfolio

We are recommending a bullish trade on  Coca-Cola (NYSE:KO).

Should You Buy Coca-Cola Stock? 3 Pros, 3 Cons (KO)

Coca-Cola stock is attractive to long-term investors, but that doesn’t mean KO is without a few downsides.

Coca-Cola Stock Looks Overextended After Earnings Pop

For now, KO stock is a name to sideline due to its rich premium compared to its peers. But in the long run – and…

The Coca-Cola Co (KO) Stock Is Expensive No Matter What Q2 Brings

Coca-Cola’s Q2 earnings, out Wednesday, could yank KO stock south. But even a good number doesn’t fix the company’s long-term problems.

How Much Fizz Is Left in Coca-Cola Stock?

Don’t let Coca-Cola’s purchase of Costa Coffee fool you. KO stock went flat for investors years ago and a cup of joe won’t revive it.

5 Ways to Slurp Up Coca-Cola’s Success

If you want to invest in Coca-Cola’s global brand, you don’t have to go straight for KO. Check out these five other ways to cash…

Coca-Cola Stock Offers Nothing Beyond the 3.2% Dividend

Here’s why you shouldn’t expect big things for The Coca-Cola Company heading into 2018.

The Coca-Cola Co (KO) Debuts Coke Ginger

The Coca-Cola Co (KO) has launched a new drink flavor called Coke Ginger in Australia that is available for a limited time.

‘Tanks’ for the Dividends!

Capital Product Partners is a powerful dividend payout performer bundled up in a small (but growing) transportation firm.

Should I Buy Coca Cola (KO) Stock? 3 Pros, 3 Cons

Is Coca Cola a buy, sell, or hold? Here are 3 pros and 3 cons to help you decide about KO stock.

Why Coca-Cola is the Best Dividend Stock You Can Buy

KO stock might not have the biggest yield, but it is one of the best, and the company is focused on expanding its beverage empire.

GMCR Stock Soars on Coca-Cola Equity Stake

Coca-Cola announced a 10% equity stake in GMCR stock and a partnership with Green Mountain for its cold-beverage Keurig, sending GMCR skyward after hours Wednesday.

Coca-Cola (KO) Chases Growth With $400 Million Chinese M&A Deal

Coca-Cola (KO) stock has trailed the S&P for 5 years, and it’s taking steps to reverse that trend with its purchase of a Chinese health…

5 – 10 of 240 results